Skip to search formSkip to main contentSkip to account menu

armodafinil

Known as: (-)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide, 2-((R)-(diphenylmethyl)sulfinyl)acetamide, (-)-2-((R)-(Diphenylmethyl)sulfinyl)acetamide 
The R-enantiomer of the racemic synthetic agent modafinil with central nervous system (CNS) stimulant and wakefulness-promoting activities. Although… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A simple, specific and fast spectrophotometric procedure has been developed for the determination of armodafinil, Pramipexole and… 
2015
2015
Modafinil is a wake promoting drug which has transformed the treatment of excessive daytime sleepiness associated with narcolepsy… 
Review
2015
Review
2015
We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) of modafinil or armodafinil (ar/mod… 
2014
2014
Addition of the drug armodafinil did not improve measures of fatigue in patients with gliomas undergoing treatment with… 
2013
2013
Dear Editor, A 54-year woman presented to our hospital with 1 week of worsening pruritic rash, 3 days of fever, watery diarrhea… 
2011
2011
Objective: To evaluate the efficacy and safety of armodafinil in the treatment of fatigue in HIV patients, and to assess its… 
Review
2010
Review
2010
Recent FDA action (through April 2010) related to Pixantrone dimaleate, Armodafinil, Rosuvastatin/fenofibric acid delayed-release… 
Review
2009
Review
2009
Recent FDA action (through November 2009) related to Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR…